Top news of the week: 15.09.2020.
#BioTech #superbugs #AMR #COVIDー19 #PREP #AiCubator #pandemics #pharma #digitalhealth
Healthcare
RT @MSollender: $GRAL GRAIL files for IPO. Developing a multi-cancer early detection blood test
$ILMN spinout
GRAIL has raised over $1.8B in private funding
Cancers detected with 99.3% specificity, with varying degree across stages: https://t.co/y8GUBU14jY
S-1: https://t.co/GeKKIzWmG8
OpenSECURITIES AND EXCHANGE COMMISSION
Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have …
After Bind bankruptcy, Hirsch once again helms a biotech, landing at C4 #BioTech via https://t.co/2sI0UxJbpn https://t.co/KOLXnoiSnw
OpenAfter Bind bankruptcy, Hirsch once again helms a biotech, landing at C4
When CEO and president at Bind Therapeutics, Andrew Hirsch had to swing the ax to his workforce, file for bankruptcy and in the end sell off its remaining assets to Pfizer.
RT @LifeSciVC: Interesting hypothesis on possible origins of SARS-CoV2. Does it's lack of mutational adaptation after jumping to humans mean it was already adapted to human cells (via lab experiments) before the outbreak?
Could COVID-19 Have Escaped from a Lab?
https://t.co/pxXn6HPrz7
OpenCould COVID-19 Have Escaped from a Lab?
The Broad Institute's Alina Chan believes it could have.
RT @Houseteamfeeds: China’s Baidu seeks to raise up to $2 billion to launch a new biotech company https://t.co/eEnOm8Sfd3
OpenChina’s Baidu is in talks to raise up to $2 billion to launch a stand-alone biotech company
The internet search giant is in discussions with investors to raise up to $2 billion over three years for a new biotech firm, a person close to the matter told CNBC.
U.S. Medical Device Firm to Acquire Developer of Dissection Stent: https://t.co/cZ3K5nv0OY
The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report.
$CRY @CryoLife https://t.co/q8A4FpEL1M
OpenU.S. Medical Device Firm to Acquire Developer of Dissection Stent Research Report
The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report.
RT @AiCuris: #COVIDー19 has taught us insistently that we need to prepare for the worst in order to prevent future #pandemics particularly those caused by #superbugs and emerging zoonoses. #PREP #AMR #AiCubator Learn more: https://t.co/ooUNXxGjnq https://t.co/qYFXiArwgs
OpenPREP: Pandemic and Resistance Emergency PreparednessPreventing the Next Global Pandemic - Tackling AMR
It has therefore to be assumed that antimicrobial resistance (AMR) or superbugs could lead to the next global emergency as their resistance to currently available antibiotics puts …
COVID-19 vaccine: PGI Rohtak to start Bharat Biotech's Covaxin's Phase-2 trials #BioTech via https://t.co/2sI0UxJbpn https://t.co/hwe97taHXt
OpenCOVID-19 Vaccine: PGI Rohtak To Start Bharat Biotech's Covaxin's Phase-2 Trials
The phase 2 clinical trial of Bharat Biotech's COVAXIN, India’s first indigenously developed vaccine against COVID-19, is all set to begin at PGI Rohtak
Debiopharm backs €10m funding by ‘digital sedation’ firm Oncomfort https://t.co/Q8Teu2WcBB #pharma #digitalhealth https://t.co/eY27RWydfx
OpenDebiopharm backs €10m funding for ‘digital sedation’ firm Oncomfort
A company that has developed a digital treatment for pain and anxiety – Belgium-based Oncomfort – has raised